Radioterapia estereotáxica intracraneal: Experiencia actualizada del Centro Médico Deán Funes

Rubén D. Llanos; Hernán Castro Vita; Patricia Quevedo; Mario Ferraris; Patricia Bruno; Gabriela Avellaneda; Mónica Brunetto; Egle Aon; Diego Franco

doi:10.56969/oc.v20i1.104

Autores/as

Rubén D. Llanos Servicio de Radiocirugía, Centro Médico Deán Funes, Córdoba
Hernán Castro Vita Centro Médico Deán Funes, Córdoba
Patricia Quevedo Servicio de Radiocirugía, Centro Médico Deán Funes, Córdoba
Mario Ferraris Centro Médico Deán Funes, Córdoba
Patricia Bruno Servicio de Radiocirugía, Centro Médico Deán Funes, Córdoba
Gabriela Avellaneda Centro Médico Deán Funes, Córdoba
Mónica Brunetto Servicio de Radiocirugía, Centro Médico Deán Funes, Córdoba
Egle Aon Servicio de Radiocirugía, Centro Médico Deán Funes, Córdoba
Diego Franco Servicio de Radiocirugía, Centro Médico Deán Funes, Córdoba

DOI:

https://doi.org/10.56969/oc.v20i1.104

Palabras clave:

radiocirugía, tumores malignos primarios, lesiones sólidas benignas, malformaciones vasculares, respuesta al tratamiento, radiosurgery, primary malignant tumors, benign solid lesions, vascular malformations, treatment response

Resumen

Se analizan los resultados de 78 pacientes irradiados con técnica de radiocirugía estereotáxica a lesiones tumorales y vasculares alojadas en el cerebro, en el Centro Médico Deán Funes, Córdoba, Argentina. Dichos tratamientos se realizaron desde agosto de 2007 hasta diciembre del 2013. El tratamiento consistió en dar una dosis única de radioterapia a lesiones de hasta 4 cm de diámetro, con una técnica de localización estereotáxica al blanco terapéutico y en las 3 dimensiones del espacio. La planificación del tratamiento se realizó con un programa de distribución de dosis de última generación. Se incluyeron en el estudio pacientes con lesiones tumorales benignas, malignas primarias y metastásicas, así como algunas malformaciones vasculares. Los resultados fueron similares a los comunicados en la literatura en términos de complicaciones y logros terapéuticos. Esta experiencia se continuó luego del cierre del estudio dada la factibilidad de realizarla en los pacientes indicados y por los resultados obtenidos.

Citas

Milano MT, Usuky KY Walker KA, Clark D, Schell MC. Ste- reotactic radiosurgery and hypofractionated stereotactic radiotherapy: normal tissue dose constraints of the central nervous system. Cancer Treat Rev 2011; 37: 567-78. DOI: https://doi.org/10.1016/j.ctrv.2011.04.004

DiBiase SJ, Chin LS: Stereotactic radiosurgery for benign neoplasms. Technol Cancer Res Treat 2003; 2: 127-34. DOI: https://doi.org/10.1177/153303460300200208

Elia AE, Shih HA, Loeffler JS. Stereotactic radiation treatment for benign meningiomas.Neurosurg Focus 2007; 23: E5. DOI: https://doi.org/10.3171/FOC-07/10/E5

Flickinger JC, Kondziolka D, Lunsford LD. Radiosurgery of benign lesions. Semin Radiat Oncol 1995; 5: 220-4. DOI: https://doi.org/10.1016/S1053-4296(05)80020-7

Lunsford LD, Kondziolka D, Flickinger JC.Stereotactic radiosurgery for benign intracranial tumors. Clin Neurosurg 1993; 40: 475-97.

DiBiase SJ, Kwok Y, Yovino S, et al. Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas. Int J Radiat Oncol Biol Phys 2004; 60: 1515-9. DOI: https://doi.org/10.1016/j.ijrobp.2004.05.073

Dufour H, Muracciole X, Métellus P, Régis J, Chinot O, GrisoliF.Long-termtumorcontrolandfunctionaloutcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery 2001; 48: 285-94. DOI: https://doi.org/10.1227/00006123-200102000-00006

Kondziolka D, Flickinger JC, Lunsford LD. The principles of skull base radiosurgery. Neurosurg Focus 2008; 24: E11. DOI: https://doi.org/10.3171/FOC/2008/24/5/E11

Lee JY, Niranjan A, McInerney J, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 2002; 97: 65-72. DOI: https://doi.org/10.3171/jns.2002.97.1.0065

Muacevic A, Jess-Hempen A, Tonn JC, Wowra B. Clinical quality standards for gamma knife radiosurgery-the Munich protocol. Acta Neurochir Suppl 2004; 91: 25-32. DOI: https://doi.org/10.1007/978-3-7091-0583-2_3

Chin LS, Szerlip NJ, Regine WF. Stereotactic radiosurgery for meningiomas. Neurosurg Focus 2003; 14: e6. DOI: https://doi.org/10.3171/foc.2003.14.5.7

Hamm KD, Gross MW, Fahrig A, et al. Stereotactic radiotherapy for the treatment of nonacoustic schwannomas. Neurosurgery 2008; 62: A29-36. DOI: https://doi.org/10.1227/01.neu.0000325934.16229.03

Régis J, Roche PH, Delsanti C, et al. Modern management of vestibular schwannomas. Prog Neurol Surg 2007; 20: 129-41. DOI: https://doi.org/10.1159/000100100

Gerber PA, Antal AS, Neumann NJ, et al. Neurofibromatosis. Eur J Med Res 2009; 14: 102-5. DOI: https://doi.org/10.1186/2047-783X-14-3-102

Datta R, Jawahar A, Ampil FL, Shi R, Nanda A, D’ Agostino H. Survival in relation to radiotherapeutic modality for brain metastasis: whole brain irradiation vs. gamma knife radiosurgery. Am J Clin Oncol 2004; 27: 420-4. DOI: https://doi.org/10.1097/01.coc.0000128863.75360.a5

Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist 2007; 12: 884-98. DOI: https://doi.org/10.1634/theoncologist.12-7-884

Kaal EC, Niel CG, Vecht CJ. Therapeutic management of brain metastasis. Lancet Neurol 2005; 4: 289-98. DOI: https://doi.org/10.1016/S1474-4422(05)70072-7

Mintz A, Perry J, Spithoff K, Chambers A, Laperriere N. Management of single brain metastasis: a practice guideline. Curr Oncol 2007; 14: 131-43. DOI: https://doi.org/10.3747/co.2007.129

Patchell RA. The management of brain metastases. Cancer Treat Rev 2003; 29: 533-40. DOI: https://doi.org/10.1016/S0305-7372(03)00105-1

Sperduto PW. A review of stereotactic radiosurgery in the management of brain metastases. Technol Cancer Res Treat 2003; 2: 105-10. DOI: https://doi.org/10.1177/153303460300200205

DiStefano A, Yong Yap Y, Hortobagiy GN, Blumenschein GR. The natural history of breast cancer patients with brain metastases. Cancer 1979; 44:1913-8. DOI: https://doi.org/10.1002/1097-0142(197911)44:5<1913::AID-CNCR2820440554>3.0.CO;2-D

Kofman S, Garvin JS, Nagamani D, Taylor SG 3rd.Treatment of cerebral metastases from breast carcinoma with prednisolone. J Am Med Assoc 1957; 163: 1473-6. DOI: https://doi.org/10.1001/jama.1957.02970510039008

Ruderman NB, Hall TC. Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer 1965; 18: 298-306. DOI: https://doi.org/10.1002/1097-0142(196503)18:3<298::AID-CNCR2820180306>3.0.CO;2-H

Egawa S, Tukiyama I, Akine Y, et al. Radiotherapy of brain metastases. Int J Radiat Oncol Biol Phys 1986; 12:1621-5. DOI: https://doi.org/10.1016/0360-3016(86)90288-9

Mandell L, Hilaris B, Sullivan M, et al. The treatment of single brain metastasis from non-oat cell carcinoma: Surgery and radiation vs. radiation therapy alone. Cancer 1986; 58: 641-9. DOI: https://doi.org/10.1002/1097-0142(19860801)58:3<641::AID-CNCR2820580308>3.0.CO;2-4

Deutsch M, Parsons JA, Mercado R Jr. Radiotherapy for intracranial metastases. Cancer 1974; 34: 1607-11. DOI: https://doi.org/10.1002/1097-0142(197411)34:5<1607::AID-CNCR2820340508>3.0.CO;2-N

Madajewicz S, Karakousis C, West CR, Caracandas J, Avellanosa AM. Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer 1984; 53: 2550-2. DOI: https://doi.org/10.1002/1097-0142(19840601)53:11<2550::AID-CNCR2820531129>3.0.CO;2-B

Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980; 6: 1-9. DOI: https://doi.org/10.1016/0360-3016(80)90195-9

Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494-500. DOI: https://doi.org/10.1056/NEJM199002223220802

Smalley SR, Laws ER Jr, O’Fallon JR, Shaw EG, Schray MF. Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients. J Neurosurg 1992; 77: 531-40. DOI: https://doi.org/10.3171/jns.1992.77.4.0531

Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33: 583-90. DOI: https://doi.org/10.1002/ana.410330605

Flickinger JC, Loeffler JS, Larson DA, et al. Stereotactic radiosurgery for intracranial malignancies. Oncology (Willinston Park) 1994; 8: 81-6; discussion 86, 94, 97-8.

Nagy G, Razak A, Rowe JG, et al. Stereotactic radiosurgery for deep-seated cavernous malformations: a move toward more active, early intervention. Clinical article. J Neurosurg 2010; 113: 691-9. DOI: https://doi.org/10.3171/2010.3.JNS091156

Szeifert GT, Kondziolka D, Levivier M, Lunsford LD, eds. Radiosurgery for Cavernous Malformations. In: Radiosurgery and Pathological Fundamentals. Prog Neurol Surg. Basel: Karger, 2007, p 220-30. DOI: https://doi.org/10.1159/000100121

Radiosurgery Practice Guideline Initiative. Stereotactic Radiosurgery for Patients with Intracranial Arteriovenous Malformations (AVM). Radiosurgery Practice Guideline Report #2-03. Issued March 2009.